ABOUT THIS PODCAST 🔗
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
Hosts:
Update frequency:
weekly
Average audio length:
50 minutes
Guest interviews
Has sponsors
English
United States
329 episodes
since April 14, 2020
episodic
AUDIENCE OF THIS PODCAST 🔗
~51.00% of listeners are from United States.
🇺🇸
US
51.00%
🇮🇪
IE
32.21%
🇩🇪
DE
2.41%
🇽🇰
XK
2.41%
🇸🇬
SG
1.61%
🇨🇦
CA
1.61%
🇬🇧
GB
1.20%
🇭🇰
HK
1.07%
🇧🇬
BG
1.07%
🇪🇸
ES
0.93%
🇨🇭
CH
0.67%
🇮🇳
IN
0.67%
🇹🇼
TW
0.53%
🇵🇭
PH
0.40%
🇯🇵
JP
0.40%
🇨🇴
CO
0.26%
🇩🇰
DK
0.26%
🇭🇷
HR
0.26%
🇷🇺
RU
0.13%
🇰🇷
KR
0.13%
🇪🇬
EG
0.13%
🇦🇷
AR
0.13%
🇺🇦
UA
0.13%
🇻🇳
VN
0.13%
🇫🇷
FR
0.13%
Others
0.12%
* Data source: directly measured on Listen Notes. real-time
LATEST EPISODE 🔗
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office, talks about his path from medical geneticist to CNS drug development and biotech investing. Bret reflects on lesso…
SEARCH PAST EPISODES
Search past episodes of Business Of Biotech.
PREVIOUS EPISODES 🔗
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management, returns to the show to talk about how SR One evaluates biotech investment targets, and the good and bad signs that eme…
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Cyriac Roeding talks about cofounding and leading Earli, a "bioAI" company using synthetic DNA switches and cancer-binding lipid nanoparticles to transform cancer cells into imm…
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Philina Lee, Ph.D., CEO at AdvanCell, explains how lead-based targeted alpha therapies can unlock deeper, more durable cancer responses, and why radiopharmaceutical companies live or die …
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the opportunity in obesity beyond GLP-1s. He describes Moonwalk’s adipose-targeted siRNA strategy, the genetics-driven…
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Independent Board Director and five-time public company CFO Alan Shaw returns to the show for an update on current biotech financing and the strategies needed to secure capital now. Allan…
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sarcomatrix, explains why the old biotech playbook breaks down in today’s funding environment and what it takes to build a lean virtual drug …
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really takes for biotech companies to attract capital, stay focused, and survive the moments when biology and execution pun…
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and funding startups and early-stage biotech companies with a focus on clinical data and differentiation as the key va…
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first FDA approval for Revtorpyk, a kinase inhibitor for breast cancer patients, and why targeting an “untreated di…
Disclaimer: The podcast and artwork embedded on this page are from Ben Comer, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
PODCAST SEARCH ENGINE
You can use our website to search 3,825,434 podcasts and 195,918,212 episodes by people, places, or topics.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
SEARCH PAST EPISODES
Search past episodes of Business Of Biotech.
CLAIM THIS PODCAST
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post classified ads for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
podcaster interview...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
our official X (formerly Twitter) account will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
EDIT
Thank you for helping to keep the podcast database up to date.
